Laura Villani

EZH2 mutational status predicts poor survival in myelofibrosis

Paola Guglielmelli, Flavia Biamonte, Joannah Score et al. · Blood · 2011 · 255 citations · Full text

Medicine, Genetics, Hematology +11

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis

Giovanni Barosi, Gaetano Bergamaschi, Monia Marchetti et al. · Blood · 2007 · 253 citations · Full text

Medicine, Genetics, Hematology +14

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2008 · 218 citations · Full text

Medicine, Genetics, Hematology +11

Anaemia characterises patients with myelofibrosis harbouring <i>Mpl</i>^{<i>W</i>515<i>L</i>/<i>K</i>} mutation

Paola Guglielmelli, Alessandro Pancrazzi, Gaetano Bergamaschi et al. · British Journal of Haematology · 2007 · 146 citations · Full text

Medicine, Genetics, Hematology +13

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation

Vittorio Rosti, Laura Villani, Roberta Riboni et al. · Blood · 2012 · 114 citations · Full text

Medicine, Genetics, Hematology +13